Howdy Partners: Von Eschenbach Pledges More Collaborations With NIH
Executive Summary
FDA Acting Commissioner Andrew von Eschenbach will champion better coordination with other federal agencies and the private sector during his temporary tenure at the agency's helm
You may also be interested in...
Avian Flu Plan From Administration Places Vaccines First, Antivirals Second
The Bush Administration's pandemic flu preparedness plans call for a dramatic expansion in the stockpiling of antivirals, an increase expected to be largely paid for by the states
CMS/NCI Will Test Model For Evidence-Based Reimbursement
A collaboration between the National Cancer Institute and the Centers for Medicare & Medicaid Services will examine cancer therapies as a model for evidence-based reimbursement, NCI Director Andrew von Eschenbach, MD, told the Milken Institute Global Conference in Los Angeles April 26-27
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011